|Bid||0.00 x 1010000|
|Ask||0.00 x 1500000|
|Day's Range||3.87 - 4.00|
|52 Week Range||2.61 - 5.64|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Measuring Proteome Sciences plc’s (AIM:PRM) track record of past performance is a useful exercise for investors. It enables us to understand whether or not the company has met or exceedRead More...
In this article, I’m going to take a look at Proteome Sciences plc’s (AIM:PRM) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject amongRead More...
For Proteome Sciences plc’s (AIM:PRM) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. The beta measuresRead More...
Proteome Sciences plc (AIM:PRM), a GBP£10.70M small-cap, is a healthcare company operating in an industry, which faces key trends such as rising demand fuelled by an aging population and theRead More...
Understanding how Proteome Sciences plc (AIM:PRM) is performing as a company requires looking at more than just a years’ earnings. Today I will run you through a basic sense checkRead More...